Skip to main content
OpenTrials

Clinical trial condition

Head and Neck Squamous Cell Carcinoma (HNSCC)

Explore clinical trials studying Head and Neck Squamous Cell Carcinoma (HNSCC). Study availability and eligibility vary by location and protocol.

31 public trials 12 recruiting studies
Refine in advanced search Browse all conditions

Head and Neck Squamous Cell Carcinoma (HNSCC) trial results

Recruiting

A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

NCT06769698

Conditions
Carcinoma, Carcinoma, Squamous Cell, Disease Attributes, +12 more
Locations
  • University of California Los Angeles Los Angeles, California, United States
  • Orlando Health Orlando, Florida, United States
  • Emory University School of Medicine Atlanta, Georgia, United States
  • St. Elizabeth Healthcare Edgewood, Kentucky, United States
View all 27 locations
View Trial Details
Recruiting

Study of Zanzalintinib in Combination With Immuno-Oncology Agents in Participants With Solid Tumors

NCT05176483

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +47 more
Locations
  • Exelixis Clinical Site #67 Phoenix, Arizona, United States
  • Exelixis Clinical Site #1 Tucson, Arizona, United States
  • Exelixis Clinical Site #123 Palo Alto, California, United States
  • Exelixis Clinical Site #59 Santa Barbara, California, United States
View all 122 locations
View Trial Details
Recruiting

Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors

NCT05985655

Conditions
Adnexal Diseases, Breast Diseases, Breast Neoplasms, +34 more
Locations
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • START Midwest Grand Rapids, Michigan, United States
  • START San Antonio San Antonio, Texas, United States
  • START Mountain Region West Valley City, Utah, United States
View all 13 locations
View Trial Details
Recruiting

A Study of MT-4561 in Patients With Various Advanced Solid Tumors

NCT06943521

Conditions
Adenocarcinoma, Adnexal Diseases, Biliary Tract Cancer, +75 more
Locations
  • University of Southern California Los Angeles, California, United States
  • START Midwest Grand Rapids, Michigan, United States
  • The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
  • The University of Texas MD Anderson Cancer Center Houston, Texas, United States
View Trial Details

Related conditions